Barbara S Schnierle

Summary

Country: Germany

Publications

  1. Henss L, Yue C, Kandler J, Faddy H, Simmons G, Panning M, et al. Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest complex. Viruses. 2019;11: pubmed publisher
    ..It might also be useful for the development of a pan-alphavirus vaccine. ..
  2. Henss L, Scholz T, Grünweller A, Schnierle B. Silvestrol Inhibits Chikungunya Virus Replication. Viruses. 2018;10: pubmed publisher
    ..From our results, we propose that inhibition of the host helicase eIF4A might have potential as a therapeutic strategy to treat CHIKV infections. ..
  3. Weber C, Sliva K, von Rhein C, Kümmerer B, Schnierle B. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection. Antiviral Res. 2015;113:1-3 pubmed publisher
    ..EGCG inhibited CHIKV infection in vitro, blocked entry of CHIKV Env-pseudotyped lentiviral vectors and inhibited CHIKV attachment to target cells. Thus EGCG might be used as a lead structure to develop more effective antiviral drugs. ..
  4. von Rhein C, Weidner T, Henß L, Martin J, Weber C, Sliva K, et al. Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro. Antiviral Res. 2016;125:51-7 pubmed publisher
    ..Although the bioavailability of these compounds is rather poor, they might be used as a lead structure to develop more effective antiviral drugs or might be used topically to prevent CHIKV spread in the skin after mosquito bites. ..
  5. Beck S, Henß L, Weidner T, Herrmann J, Müller R, Chao Y, et al. Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library. Antiviral Res. 2016;132:85-91 pubmed publisher
  6. Henß L, Beck S, Weidner T, Biedenkopf N, Sliva K, Weber C, et al. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry. Virol J. 2016;13:149 pubmed publisher